248 related articles for article (PubMed ID: 12785871)
21. Combining hepatitis A and B vaccination in children and adolescents.
Van Damme P; Van der Wielen M
Vaccine; 2001 Mar; 19(17-19):2407-12. PubMed ID: 11257370
[TBL] [Abstract][Full Text] [Related]
22. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
[TBL] [Abstract][Full Text] [Related]
23. [Acute hepatitis A despite combined vaccination against hepatitis A and B--re the article from DMW 30/2002, page 1581-3].
Lander T
Dtsch Med Wochenschr; 2002 Nov; 127(46):2466-7; author reply 2467. PubMed ID: 12432491
[No Abstract] [Full Text] [Related]
24. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
[TBL] [Abstract][Full Text] [Related]
25. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
Van Herck K; Van Damme P; Collard F; Thoelen S
Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
[TBL] [Abstract][Full Text] [Related]
26. A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults.
Beran J; Chlibek R; Weber F
Vaccine; 2003 Dec; 21(32):4650-4. PubMed ID: 14585671
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
28. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
29. [Immunization recommendations for travel in the Mediterranean area].
Rendi-Wagner P; Hoeller K; Kollaritsch H;
Wien Klin Wochenschr; 2004 Oct; 116(19-20):652-60. PubMed ID: 15941073
[TBL] [Abstract][Full Text] [Related]
30. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
31. A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix(®) in subjects aged 11-17 years: an open, randomised, controlled trial.
Østergaard L; Silfverdal SA; Berglund J; Flodmark CE; West C; Bianco V; Baine Y; Miller JM
Vaccine; 2012 Jan; 30(4):774-83. PubMed ID: 22107850
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.
Bakker M; Bunge EM; Marano C; de Ridder M; De Moerlooze L
Expert Rev Vaccines; 2016 Jul; 15(7):829-51. PubMed ID: 26840060
[TBL] [Abstract][Full Text] [Related]
33. An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
Jong EC; Kaplan KM; Eves KA; Taddeo CA; Lakkis HD; Kuter BJ
J Travel Med; 2002; 9(2):66-70. PubMed ID: 12044272
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis and typhoid vaccine: killing two birds with one stone.
Tucker R
Community Nurse; 1999 Nov; 5(10):41-2. PubMed ID: 10732550
[No Abstract] [Full Text] [Related]
35. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
Beran J; Kervyn D; Wertzova V; Hobzova L; Tichy P; Kuriyakose S; Leyssen M; Jacquet JM
Vaccine; 2010 Aug; 28(37):5993-7. PubMed ID: 20637766
[TBL] [Abstract][Full Text] [Related]
36. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
37. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
[TBL] [Abstract][Full Text] [Related]
38. Severe bilateral optic neuritis post hepatitis A virus (HAV) and typhoid fever vaccination.
O'Dowd S; Bafiq R; Ryan A; Cullinane A; Costello D
J Neurol Sci; 2015 Oct; 357(1-2):300-1. PubMed ID: 26145200
[No Abstract] [Full Text] [Related]
39. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
40. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years.
Levie K; Beran J; Collard F; Nguyen C
Vaccine; 2002 Jun; 20(19-20):2579-84. PubMed ID: 12057615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]